Literature DB >> 25705438

Crystal structures of 2-benzyl-amino-4-(4-bromo-phen-yl)-6,7,8,9-tetra-hydro-5H-cyclo-hepta-[b]pyridine-3-carbo-nitrile and 2-benzyl-amino-4-(4-chloro-phen-yl)-6,7,8,9-tetra-hydro-5H-cyclo-hepta[b]pyridine-3-carbo-nitrile.

R A Nagalakshmi1, J Suresh1, S Maharani2, R Ranjith Kumar2, P L Nilantha Lakshman3.   

Abstract

In the title compounds, C24H22BrN3, (I), and C24H22ClN3, (II), the 2-amino-pyridine ring is fused with a cyclo-heptane ring, which adopts a half-chair conformation. The planes of the phenyl and benzene rings are inclined to that of the central pyridine ring [r.m.s. deviations = 0.0083 (1) and 0.0093 (1) Å for (I) and (II), respectively] by 62.47 (17) and 72.51 (14)°, respectively, in (I), and by 71.44 (9) and 54.90 (8)°, respectively, in (II). The planes of the aromatic rings are inclined to one another by 53.82 (17)° in (I) and by 58.04 (9)° in (II). In the crystals of both (I) and (II), pairs of N-H⋯Nnitrile hydrogen bonds link the mol-ecules, forming inversion dimers with R 2 (2)(12) ring motifs. In (I), the resulting dimers are connected through C-H⋯Br hydrogen bonds, forming sheets parallel to (10-1), and π-π inter-actions [inter-centroid distance = 3.7821 (16) Å] involving inversion-related pyridine rings, forming a three-dimensional network. In (II), the resulting dimers are connected through π-π inter-actions [inter-centroid distance = 3.771 (2) Å] involving inversion-related pyridine rings, forming a two-dimensional network lying parallel to (001).

Entities:  

Keywords:  carbo­nitrile; crystal structure; cyclo­hepta­[b]pyridine; hydrogen bonding; π–π inter­actions

Year:  2015        PMID: 25705438      PMCID: PMC4331894          DOI: 10.1107/S2056989014025936

Source DB:  PubMed          Journal:  Acta Crystallogr E Crystallogr Commun


Chemical context

The heterocyclic skeleton containing a nitro­gen atom is the basis of many essential pharmaceuticals and of many physiologically active natural products. Mol­ecules containing heterocyclic substructures continue to be attractive targets for synthesis since they often exhibit diverse and important biological properties. Pyridine is used in the pharmaceutical industry as a raw material for various drugs, vitamins and fungicides, and as a solvent (Shinkai et al., 2000 ▸; Jansen et al., 2001 ▸; Amr et al., 2006 ▸). Pyridines are also omnipresent in medicaments and in agrochemicals (Tomlin, 1994 ▸). Pyridine derivatives have occupied a unique position in medicinal chemistry. Among them, 2-amino-3-cyano­pyridines have been identified as IKK-β inhibitors (Murata et al., 2003 ▸). Many fused cyano­pyridines have also been shown to have a wide spectrum of biological activity (Boschelli et al., 2004 ▸). Our inter­est in the preparation of pharmacologically active 3-cyano­pyridine compounds led us to synthesize the title compounds and we report herein on their crystal structures.

Structural commentary

The mol­ecular structures of the title compounds, (I) and (II), are shown in Figs. 1 ▸ and 2 ▸, respectively. The bromo derivative (I), crystallizes in the monoclinic space group P21/n while the chloro derivative (II), crystallizes in the triclinic space group P .
Figure 1

The mol­ecular structure of compound (I), showing 50% probability displacement ellipsoids and the atom labelling.

Figure 2

The mol­ecular structure of (II), showing 50% probability displacement ellipsoids and the atom labelling.

In both compounds, the pyridine ring is connected to a benzene ring by a –CH2—NH2– chain, as found in a similar structure N 6-(4-fluoro­benz­yl)-3-nitro­pyridine-2,6-di­amine (Ge & Qian, 2011 ▸). As expected, the pyridine ring (C2–C6/N3) is planar with r.m.s. deviations of 0.0083 and 0.0093 Å in compounds (I) and (II), respectively. In both compounds, the cyclo­heptane ring adopts a half-chair conformation, with puckering parameters Q2 = 0.415 (3) Å, ϕ2 = 310.1 (4)° and Q3 = 0.637 (3) Å and ϕ3 = 283.4 (3)° for compound (I) and Q2 = 0.475 (2) Å, ϕ2 = 310.3 (2)° and Q3 = 0.635 (2) Å and ϕ3 = 283.58 (17)° for compound (II). The amine N atom, N2, attached to the pyridine ring (N3/C2–C6) deviates by only 0.0107 (1) and 0.0073 (1) Å from the ring plane in (I) and (II), respectively. Steric hindrance rotates the benzene ring (C31–C36) out of the plane of the central pyridine ring by 72.51 (14)° in compound (I) and by only 54.90 (8)° in compound (II). The benzene ring is inclined to the phenyl ring (C22–C27) by 53.82 (17) in (I) and by 58.04 (9)° in (II).

Supra­molecular features

In the crystal of (I), mol­ecules are linked by pairs of N—H⋯Nnitrile hydrogen bonds, forming inversion dimers with (12) ring motifs (Table 1 ▸ and Fig. 3 ▸). The resulting dimers are connected through C—H⋯Br hydrogen bonds, forming sheets lying parallel to (10). The sheets are connected by weak π–π stacking inter­actions involving adjacent inversion-related pyridine rings with a centroid-to-centroid distance of 3.7710 (7) Å, as shown in Fig. 3 ▸. These inter­actions lead to the formation of a three-dimensional network.
Table 1

Hydrogen-bond geometry (, ) for (I)

DHA DHHA D A DHA
N2H2N1i 0.862.283.010(3)143
C21H21BBr1ii 0.972.903.703(3)141

Symmetry codes: (i) ; (ii) .

Figure 3

Crystal packing diagram of compound (I), viewed along the b axis. Hydrogen bonds (see Table 1 ▸ for details) and π–π inter­actions are shown as dashed lines (centroids are shown as small circles). H atoms not involved in hydrogen bonding have been omitted for clarity.

In the crystal of (II), mol­ecules are also linked by pairs of N—H⋯Nnitrile hydrogen bonds, forming inversion dimers with (12) ring motifs (Table 2 ▸ and Fig. 4 ▸). The dimers are connected through weak π–π inter­actions involving inversion-related pyridine rings with a centroid-to-centroid distance of 3.7818 (2) Å (Fig. 4 ▸). The resulting structure is a two-dimensional network lying parallel to (001).
Table 2

Hydrogen-bond geometry (, ) for (II)

DHA DHHA D A DHA
N2H2N1i 0.862.263.007(2)145

Symmetry code: (i) .

Figure 4

Crystal packing diagram of compound (II), viewed along the b axis. Hydrogen bonds (see Table 2 ▸ for details) and π–π inter­actions are shown as dashed lines (centroids are shown as small circles). H atoms not involved in hydrogen bonding have been omitted for clarity.

Synthesis and crystallization

Compounds (I) and (II) were prepared in a similar manner using 4-bromo aldehyde (1 mmol) for compound (I) and 4-chloro aldehyde (1 mmol) for compound (II). A mixture of cyclo­hepta­none (1 mmol), aromatic aldehyde (1 mmol), malono­nitrile (1 mmol) and benzyl­amine (1mmol) were taken in ethanol (10 ml) to which p-TSA (p-toluene­sulfonic acid) (1.0 mmol) was added. The reaction mixture was heated under reflux for 2–3 h. On completion of the reaction, verified by thin-layer chromatography (TLC), the mixture was poured into crushed ice and extracted with ethyl acetate. The excess solvent was removed under vacuum and the residue was subjected to column chromatography using a petroleum ether/ethyl acetate mixture (97:3 v/v) as eluent to afford the pure products. They were recrystallized from ethyl acetate, giving colourless crystals of compounds (I) [m.p. 417 K; yield 74%] and (II) [m.p. 397 K; yield 75%].

Database survey

A similar structure reported in the literature, 2-(4-bromophen­yl)-4-(4-meth­oxy­phen­yl)-6,7,8,9-tetra­hydro-5H-cyclohepta­[b]pyridine (Çelik et al., 2013 ▸) also has a chair conformation of the cyclo­heptane ring and a planar conformation of the pyridine ring, as found for (I) and (II). In compounds (I) and (II) the C—N bond lengths in the –CH2—NH2– chain, viz. C6—N2 and C21—N2, are 1.350 (3) and 1.441 (3) Å, respectively, in (I) and 1.354 (2) and 1.442 (2) Å, respectively, in (II). These distances are similar to those reported for N 6-(4-fluoro­benz­yl)-3-nitro­pyridine-2,6-di­amine (Ge & Qian, 2011 ▸), viz. 1.341 (3) and 1.454 (3) Å, respectively.

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 3 ▸. The NH and C-bound H atoms were placed in calculated positions and allowed to ride on their carrier atoms: N—H = 0.86 Å and C—H = 0.93–0.97 Å with U iso(H) = 1.5U eq(C) for methyl H atoms and = 1.2U eq(N,C) for other H atoms.
Table 3

Experimental details

 (I)(II)
Crystal data
Chemical formulaC24H22BrN3 C24H22ClN3
M r 432.35387.89
Crystal system, space groupMonoclinic, P21/n Triclinic, P
Temperature (K)293293
a, b, c ()8.9710(3), 9.3794(4), 24.9788(9)9.002(5), 10.097(5), 11.856(5)
, , ()90, 99.002(2), 9094.939(5), 108.204(5), 101.272(5)
V (3)2075.89(14)991.3(8)
Z 42
Radiation typeMo K Mo K
(mm1)1.990.21
Crystal size (mm)0.21 0.19 0.180.21 0.19 0.18
 
Data collection
DiffractometerBruker Kappa APEXIIBruker Kappa APEXII
Absorption correctionMulti-scan (SADABS; Bruker, 2004)Multi-scan (SADABS; Bruker, 2004)
T min, T max 0.967, 0.9740.967, 0.974
No. of measured, independent and observed [I > 2(I)] reflections51599, 3863, 292724808, 3685, 2918
R int 0.0400.026
(sin /)max (1)0.6060.606
 
Refinement
R[F 2 > 2(F 2)], wR(F 2), S 0.041, 0.099, 1.100.037, 0.105, 1.05
No. of reflections38633685
No. of parameters253253
No. of restraints01
H-atom treatmentH-atom parameters constrainedH-atom parameters constrained
max, min (e 3)0.42, 0.580.19, 0.33

Computer programs: APEX2 and SAINT (Bruker, 2004 ▸), SHELXS97, SHELXL97 and SHELXL2014 (Sheldrick, 2008 ▸) and PLATON (Spek, 2009 ▸).

Crystal structure: contains datablock(s) global, I, II. DOI: 10.1107/S2056989014025936/su5027sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989014025936/su5027Isup2.hkl Structure factors: contains datablock(s) II. DOI: 10.1107/S2056989014025936/su5027IIsup3.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989014025936/su5027Isup4.cml Click here for additional data file. Supporting information file. DOI: 10.1107/S2056989014025936/su5027IIsup5.cml CCDC references: 1036150, 1036149 Additional supporting information: crystallographic information; 3D view; checkCIF report
C24H22ClN3Z = 2
Mr = 387.89F(000) = 408
Triclinic, P1Dx = 1.299 Mg m3
a = 9.002 (5) ÅMo Kα radiation, λ = 0.71073 Å
b = 10.097 (5) ÅCell parameters from 2000 reflections
c = 11.856 (5) Åθ = 2–31°
α = 94.939 (5)°µ = 0.21 mm1
β = 108.204 (5)°T = 293 K
γ = 101.272 (5)°Block, colourless
V = 991.3 (8) Å30.21 × 0.19 × 0.18 mm
Bruker Kappa APEXII diffractometer2918 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeRint = 0.026
ω and φ scansθmax = 25.5°, θmin = 2.1°
Absorption correction: multi-scan (SADABS; Bruker, 2004)h = −10→10
Tmin = 0.967, Tmax = 0.974k = −12→12
24808 measured reflectionsl = −14→14
3685 independent reflections
Refinement on F21 restraint
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.037H-atom parameters constrained
wR(F2) = 0.105w = 1/[σ2(Fo2) + (0.0486P)2 + 0.3383P] where P = (Fo2 + 2Fc2)/3
S = 1.05(Δ/σ)max < 0.001
3685 reflectionsΔρmax = 0.19 e Å3
253 parametersΔρmin = −0.33 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
xyzUiso*/Ueq
C10.1170 (2)0.47342 (18)0.36822 (15)0.0401 (4)
C20.24864 (18)0.41014 (15)0.38041 (14)0.0327 (3)
C30.32569 (17)0.40885 (15)0.29430 (13)0.0304 (3)
C40.44508 (17)0.33539 (15)0.30821 (14)0.0321 (3)
C50.48147 (17)0.26963 (15)0.40915 (14)0.0331 (3)
C60.29611 (17)0.34315 (15)0.48044 (14)0.0320 (3)
C70.53288 (19)0.32240 (17)0.21988 (15)0.0395 (4)
H7A0.64780.34890.26310.047*
H7B0.50740.38540.16330.047*
C80.4910 (2)0.17808 (19)0.14983 (16)0.0477 (4)
H8A0.37600.14110.12740.057*
H8B0.51580.18390.07620.057*
C90.5782 (3)0.0790 (2)0.21741 (18)0.0540 (5)
H9A0.5446−0.00860.16520.065*
H9B0.69260.11240.23360.065*
C100.5522 (2)0.05584 (19)0.33498 (18)0.0516 (5)
H10A0.6113−0.01040.36850.062*
H10B0.43890.01630.31840.062*
C110.6037 (2)0.18367 (19)0.42923 (16)0.0451 (4)
H11A0.62230.15650.50810.054*
H11B0.70460.23860.42850.054*
C210.2814 (2)0.29636 (18)0.67846 (15)0.0416 (4)
H21A0.32400.37400.74280.050*
H21B0.36920.25400.67810.050*
C220.15556 (19)0.19495 (16)0.70552 (14)0.0347 (3)
C230.1853 (2)0.16979 (18)0.82224 (16)0.0449 (4)
H230.27890.21890.88230.054*
C240.0778 (3)0.0727 (2)0.85090 (19)0.0589 (5)
H240.09960.05640.92980.071*
C25−0.0605 (3)0.0004 (2)0.7635 (2)0.0629 (6)
H25−0.1323−0.06580.78260.075*
C26−0.0929 (2)0.0256 (2)0.6480 (2)0.0617 (5)
H26−0.1877−0.02280.58860.074*
C270.0142 (2)0.12280 (19)0.61870 (17)0.0503 (4)
H27−0.00920.13960.53990.060*
C310.28089 (17)0.49110 (15)0.19592 (14)0.0321 (3)
C320.2876 (2)0.62890 (17)0.22518 (15)0.0396 (4)
H320.32230.66830.30560.047*
C330.2437 (2)0.70820 (18)0.13681 (17)0.0459 (4)
H330.24910.80040.15740.055*
C340.19207 (19)0.64947 (18)0.01821 (16)0.0428 (4)
C350.1840 (2)0.51340 (19)−0.01437 (16)0.0454 (4)
H350.14930.4748−0.09500.055*
C360.2284 (2)0.43515 (17)0.07516 (15)0.0395 (4)
H360.22310.34300.05400.047*
N10.0094 (2)0.51850 (19)0.36511 (16)0.0616 (5)
N20.22527 (17)0.34558 (15)0.56572 (13)0.0425 (3)
H20.14130.37860.55170.051*
N30.41191 (15)0.27423 (13)0.49346 (11)0.0349 (3)
Cl10.13087 (7)0.74901 (6)−0.09170 (5)0.06667 (19)
U11U22U33U12U13U23
C10.0457 (9)0.0481 (10)0.0398 (9)0.0242 (8)0.0226 (7)0.0144 (7)
C20.0336 (7)0.0323 (8)0.0369 (8)0.0132 (6)0.0151 (6)0.0062 (6)
C30.0315 (7)0.0271 (8)0.0337 (8)0.0084 (6)0.0118 (6)0.0038 (6)
C40.0294 (7)0.0317 (8)0.0382 (8)0.0096 (6)0.0141 (6)0.0050 (6)
C50.0307 (7)0.0328 (8)0.0362 (8)0.0110 (6)0.0104 (6)0.0028 (6)
C60.0328 (8)0.0297 (8)0.0369 (8)0.0093 (6)0.0153 (6)0.0047 (6)
C70.0368 (8)0.0452 (9)0.0472 (9)0.0170 (7)0.0224 (7)0.0144 (8)
C80.0523 (10)0.0567 (11)0.0441 (10)0.0229 (9)0.0246 (8)0.0062 (8)
C90.0662 (12)0.0486 (11)0.0619 (12)0.0279 (9)0.0335 (10)0.0071 (9)
C100.0646 (12)0.0436 (10)0.0629 (12)0.0302 (9)0.0318 (10)0.0148 (9)
C110.0454 (9)0.0549 (11)0.0453 (10)0.0294 (8)0.0172 (8)0.0146 (8)
C210.0435 (9)0.0471 (10)0.0368 (9)0.0101 (8)0.0168 (7)0.0088 (7)
C220.0398 (8)0.0331 (8)0.0381 (8)0.0154 (7)0.0184 (7)0.0066 (6)
C230.0513 (10)0.0473 (10)0.0398 (9)0.0150 (8)0.0171 (8)0.0111 (8)
C240.0745 (14)0.0608 (13)0.0570 (12)0.0228 (11)0.0345 (11)0.0288 (10)
C250.0589 (12)0.0536 (12)0.0923 (16)0.0156 (10)0.0404 (12)0.0339 (12)
C260.0479 (11)0.0535 (12)0.0764 (14)0.0035 (9)0.0144 (10)0.0156 (11)
C270.0498 (10)0.0527 (11)0.0455 (10)0.0092 (9)0.0127 (8)0.0119 (8)
C310.0298 (7)0.0341 (8)0.0386 (8)0.0116 (6)0.0167 (6)0.0094 (6)
C320.0413 (9)0.0368 (9)0.0408 (9)0.0121 (7)0.0123 (7)0.0060 (7)
C330.0460 (9)0.0332 (9)0.0594 (11)0.0111 (7)0.0164 (8)0.0136 (8)
C340.0384 (9)0.0483 (10)0.0500 (10)0.0146 (8)0.0195 (8)0.0240 (8)
C350.0499 (10)0.0558 (11)0.0370 (9)0.0171 (8)0.0196 (8)0.0115 (8)
C360.0457 (9)0.0380 (9)0.0416 (9)0.0158 (7)0.0206 (7)0.0072 (7)
N10.0655 (10)0.0839 (13)0.0638 (11)0.0493 (10)0.0377 (9)0.0285 (9)
N20.0472 (8)0.0511 (9)0.0466 (8)0.0259 (7)0.0281 (7)0.0202 (7)
N30.0366 (7)0.0351 (7)0.0366 (7)0.0145 (6)0.0135 (6)0.0072 (6)
Cl10.0687 (3)0.0744 (4)0.0699 (3)0.0251 (3)0.0271 (3)0.0466 (3)
C1—N11.140 (2)C21—C221.505 (2)
C1—C21.428 (2)C21—H21A0.9700
C2—C31.403 (2)C21—H21B0.9700
C2—C61.408 (2)C22—C271.378 (3)
C3—C41.398 (2)C22—C231.381 (2)
C3—C311.489 (2)C23—C241.380 (3)
C4—C51.399 (2)C23—H230.9300
C4—C71.508 (2)C24—C251.366 (3)
C5—N31.337 (2)C24—H240.9300
C5—C111.505 (2)C25—C261.366 (3)
C6—N31.340 (2)C25—H250.9300
C6—N21.354 (2)C26—C271.382 (3)
C7—C81.529 (3)C26—H260.9300
C7—H7A0.9700C27—H270.9300
C7—H7B0.9700C31—C361.388 (2)
C8—C91.520 (3)C31—C321.389 (2)
C8—H8A0.9700C32—C331.380 (2)
C8—H8B0.9700C32—H320.9300
C9—C101.513 (3)C33—C341.373 (3)
C9—H9A0.9700C33—H330.9300
C9—H9B0.9700C34—C351.376 (3)
C10—C111.524 (3)C34—Cl11.7334 (17)
C10—H10A0.9700C35—C361.383 (2)
C10—H10B0.9700C35—H350.9300
C11—H11A0.9700C36—H360.9300
C11—H11B0.9700N2—H20.8600
C21—N21.442 (2)
N1—C1—C2174.73 (18)N2—C21—C22114.79 (14)
C3—C2—C6120.15 (13)N2—C21—H21A108.6
C3—C2—C1122.07 (14)C22—C21—H21A108.6
C6—C2—C1117.73 (14)N2—C21—H21B108.6
C4—C3—C2118.39 (14)C22—C21—H21B108.6
C4—C3—C31123.49 (13)H21A—C21—H21B107.5
C2—C3—C31118.06 (13)C27—C22—C23118.37 (16)
C3—C4—C5117.26 (13)C27—C22—C21123.14 (15)
C3—C4—C7123.47 (14)C23—C22—C21118.46 (15)
C5—C4—C7119.26 (13)C24—C23—C22120.88 (18)
N3—C5—C4124.52 (14)C24—C23—H23119.6
N3—C5—C11114.38 (14)C22—C23—H23119.6
C4—C5—C11121.08 (14)C25—C24—C23120.05 (19)
N3—C6—N2118.13 (14)C25—C24—H24120.0
N3—C6—C2120.89 (13)C23—C24—H24120.0
N2—C6—C2120.98 (13)C24—C25—C26119.80 (19)
C4—C7—C8113.51 (14)C24—C25—H25120.1
C4—C7—H7A108.9C26—C25—H25120.1
C8—C7—H7A108.9C25—C26—C27120.40 (19)
C4—C7—H7B108.9C25—C26—H26119.8
C8—C7—H7B108.9C27—C26—H26119.8
H7A—C7—H7B107.7C22—C27—C26120.48 (18)
C9—C8—C7114.77 (15)C22—C27—H27119.8
C9—C8—H8A108.6C26—C27—H27119.8
C7—C8—H8A108.6C36—C31—C32118.14 (14)
C9—C8—H8B108.6C36—C31—C3122.71 (14)
C7—C8—H8B108.6C32—C31—C3119.13 (14)
H8A—C8—H8B107.6C33—C32—C31121.05 (16)
C10—C9—C8116.06 (15)C33—C32—H32119.5
C10—C9—H9A108.3C31—C32—H32119.5
C8—C9—H9A108.3C34—C33—C32119.28 (16)
C10—C9—H9B108.3C34—C33—H33120.4
C8—C9—H9B108.3C32—C33—H33120.4
H9A—C9—H9B107.4C33—C34—C35121.39 (16)
C9—C10—C11115.01 (16)C33—C34—Cl1118.72 (14)
C9—C10—H10A108.5C35—C34—Cl1119.86 (14)
C11—C10—H10A108.5C34—C35—C36118.70 (16)
C9—C10—H10B108.5C34—C35—H35120.6
C11—C10—H10B108.5C36—C35—H35120.6
H10A—C10—H10B107.5C35—C36—C31121.43 (16)
C5—C11—C10113.24 (15)C35—C36—H36119.3
C5—C11—H11A108.9C31—C36—H36119.3
C10—C11—H11A108.9C6—N2—C21124.26 (14)
C5—C11—H11B108.9C6—N2—H2117.9
C10—C11—H11B108.9C21—N2—H2117.9
H11A—C11—H11B107.7C5—N3—C6118.73 (13)
D—H···AD—HH···AD···AD—H···A
N2—H2···N1i0.862.263.007 (2)145
  9 in total

1.  Dinuclear alkyldiamine platinum antitumor compounds: a structure-activity relationship study.

Authors:  B A Jansen; J van der Zwan; H den Dulk; J Brouwer; J Reedijk
Journal:  J Med Chem       Date:  2001-01-18       Impact factor: 7.446

2.  Identification of 7-phenylaminothieno- [3,2-b]pyridine-6-carbonitriles as a new class of Src kinase inhibitors.

Authors:  Diane H Boschelli; Biqi Wu; Ana Carolina Barrios Sosa; Haris Durutlic; Fei Ye; Yuri Raifeld; Jennifer M Golas; Frank Boschelli
Journal:  J Med Chem       Date:  2004-12-30       Impact factor: 7.446

3.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

4.  4-Aminoquinolines: novel nociceptin antagonists with analgesic activity.

Authors:  H Shinkai; T Ito; T Iida; Y Kitao; H Yamada; I Uchida
Journal:  J Med Chem       Date:  2000-11-30       Impact factor: 7.446

5.  Anticancer activities of some newly synthesized pyridine, pyrane, and pyrimidine derivatives.

Authors:  Abdel-Galil E Amr; Ashraf M Mohamed; Salwa F Mohamed; Nagla A Abdel-Hafez; Abu El-Fotooh G Hammam
Journal:  Bioorg Med Chem       Date:  2006-05-18       Impact factor: 3.641

6.  Discovery of novel and selective IKK-beta serine-threonine protein kinase inhibitors. Part 1.

Authors:  Toshiki Murata; Mitsuyuki Shimada; Sachiko Sakakibara; Takashi Yoshino; Hiroshi Kadono; Tsutomu Masuda; Makoto Shimazaki; Takuya Shintani; Kinji Fuchikami; Katsuya Sakai; Hisayo Inbe; Keisuke Takeshita; Toshiro Niki; Masaomi Umeda; Kevin B Bacon; Karl B Ziegelbauer; Timothy B Lowinger
Journal:  Bioorg Med Chem Lett       Date:  2003-03-10       Impact factor: 2.823

7.  2-(4-Bromo-phen-yl)-4-(4-meth-oxy-phen-yl)-6,7,8,9-tetra-hydro-5H-cyclo-hepta-[b]pyridine.

Authors:  Ismail Celik; Mehmet Akkurt; Hayreddin Gezegen; Canan Kazak
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-05-25

8.  N-(4-Fluoro-benz-yl)-3-nitro-pyridine-2,6-diamine.

Authors:  Ji-Long Ge; Xiao-Min Qian
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-05-20

9.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  9 in total
  1 in total

1.  Speculative assessment, molecular composition, PDOS, topology exploration (ELF, LOL, RDG), ligand-protein interactions, on 5-bromo-3-nitropyridine-2-carbonitrile.

Authors:  K Arulaabaranam; S Muthu; G Mani; A S Ben Geoffrey
Journal:  Heliyon       Date:  2021-05-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.